How to Build a Traceable Genomics Laboratory Workflow

Those questions are central to a regulated laboratory environment. CLIA’s objective is accurate, reliable, and timely laboratory testing, with requirements that become more stringent as testing grows more complex CMS guidance also calls for a quality system across the preanalytic, analytic, and postanalytic phases of nonwaived testing, plus an information or record system that accurately and reliably sends patient-specific data to the final report destination (CMS CLIA guidance).

Why Genomics Laboratory Workflows Break as Volume Grows

As genomics and advanced diagnostics programs grow, the difficult part is rarely producing another data file. The harder problem is preserving the clinical context, system traceability, and review controls needed to turn that file into a reliable report.

This creates workflow debt. It appears in the work that does not show up in a formal process map: the message sent to clarify a requisition, the spreadsheet used to reconcile an interface, the call made to confirm a case status, or the reviewer’s effort to determine which version of a report is current.

Consider an anonymized laboratory with multiple ordering sources, an established LIS and EHR environment, laboratory-specific bioinformatics pipelines, and high expectations for predictable turnaround. One system may hold order information, another laboratory status, another analysis activity, and a separate process the final clinical narrative. When the connections between those steps are informal, the team has to rebuild context whenever an exception occurs.

Unstructured or incomplete requisitions are a common starting point. A missing phenotype, ordering context, consent status, or requested analysis may seem like a small omission when the request arrives. It becomes much more consequential once a specimen has been received, analysis has begun, and the team needs to determine whether the case can proceed.

Interface fragility creates a related problem. A message may be sent but not acknowledged, or a status may be updated in one system but not another. Without clear ownership and reconciliation, teams can spend time asking which source is authoritative rather than resolving the issue itself.

Genomics Workflow Architecture: Design Objectives and Constraints

A traceable workflow begins by turning each requisition into a validated, structured case record before it enters the LIS.

SmartReq is an on-premise AI intake layer designed for the reality of genetics-lab requisitions: handwritten forms, faxed or degraded scans, and multiple referring-provider templates. It preprocesses documents, identifies the form type, extracts printed and handwritten fields into the lab’s schema, and validates the results against defined rules, such as required fields, date formats, insurance-ID patterns, and recognized ICD-10 codes.

Clean records can move forward, while low-confidence extraction, missing information, or validation failures are routed for human review. Reviewers see the extracted data alongside the source form and can correct only the flagged fields rather than re-keying the entire requisition. The system preserves the document, extraction outcome, validation result, and manual changes in an audit trail.

This creates a controlled intake point: errors are caught before LIS entry, while the lab retains existing downstream systems and uses human review where judgment is actually required.

Structured Requisition Intake for a Reliable Genomics Workflow

The workflow begins before analysis. SmartReq provides a structured requisition-intake step so required fields, clinical context, and routing information can be captured before the case enters downstream processing.

The practical value is not merely a cleaner form. It is a way to identify missing information at the point where it can be corrected most easily. Missing phenotype details, consent status, analysis requests, or ordering context can lead to manual clarification after accessioning.

Structured intake is therefore a control mechanism, not merely a user-interface improvement. It determines whether the workflow begins with reliable context or with uncertainty that must be managed later. A visible exception queue turns an incomplete or inconsistent requisition into a defined operational task, with a clear owner and next action.

LIS and EHR Integration for Stable Laboratory Data Flow

EHR integration should do more than pass orders into the LIS. It should stop incomplete and duplicate orders before they create downstream work.

Intergenix can sit alongside the EHR integration pipeline and apply configurable rules to every incoming order. It checks whether required demographics, insurance information, ICD-10 codes, provider identifiers, and other laboratory-defined fields are present and valid. Orders that fail are classified with actionable statuses such as missing data, invalid, duplicate, or in follow-up, rather than failing silently.

It also detects likely duplicates, such as repeat transmissions caused by EHR retries, clinic resubmissions, or interface errors, using configurable matching criteria including patient, test, ordering provider, and time window. Potential duplicates are consolidated or routed for review before duplicate cases enter downstream systems

Real-time dashboards give operations and client-services teams visibility into order volumes, status, failure reasons, and recurring issues by clinic or EHR source. This turns follow-up from reactive troubleshooting into targeted action on the specific information needed to move an order forward.

Variant Review, Audit Trails, and Genomics Case Management

Varion supports the organization of evidence and review activity during variant analysis. The workflow value comes from associating analytical context, reviewer actions, and decision history with the case. A reviewer should not have to reconstruct the logic behind a previous action from disconnected notes or system timestamps.

The workflow also needs a shared language for the case lifecycle. An illustrative state progression may be received, verified, accessioned, analysis in progress, review required, approved, reported, and delivered. The final state names should reflect the laboratory’s approved terminology, but each state should have a clear meaning, responsible role, and next permitted action.

Auditability must be designed into the workflow from the beginning. Significant events, user actions, rule outcomes, document versions, and approval decisions should be retrievable in the context of a specific case. A list of timestamps is not enough if it cannot explain what changed, who acted, and which version was in effect.

Where electronic protected health information is involved, HHS describes audit controls as mechanisms that record and examine activity in relevant information systems (HHS guidance on audit controls). The workflow architecture can support that operating discipline, while laboratory governance remains responsible for validation, authorization, quality procedures, and access-control decisions.

Workflow layer in context: An architecture diagram showing order sources to SmartReq, integration to LIS/EHR and accessioning, validated bioinformatics pipeline, Varion review, ReportStudio, and finalized report delivery.

Clinical Reporting Workflow and Controlled Report Release

ReportStudio provides the controlled reporting layer for drafting, versioning, approving, and releasing clinical reports. The architectural principle is separation with continuity. Reviewers need the appropriate evidence and decision history. Report authors need an approved, current record. Operators need to see whether a case is waiting for review, report authorization, release, or exception resolution.

Drafting, review, authorization, and release should remain distinct workflow actions. Version control and release checks help prevent a superseded or unapproved report from being delivered. This separation does not make the workflow more complicated for its own sake. It makes the responsibilities and control points clear when a report is revised, returned for further review, or ready to be released.

Genomics Workflow Implementation and Validation Scenarios

Implementation should begin with discovery of the current-state workflow. That means looking beyond the documented procedure to the handoffs and exception paths that operators use every day. The most important details are often informal: a status check made outside the system, a spreadsheet used to track a case, or an experienced team member who knows how to interpret a failed message.

Before workflow rules are configured, define data ownership and interface contracts. Decide who resolves a failed message, a duplicate case, missing clinical context, pipeline-handoff issues, and corrected reports. These questions are not administrative extras. They determine whether a workflow can be operated consistently after go-live.

Validation should then proceed in stages. Test ordinary requisitions and expected messages. Test incomplete orders, amended requests, duplicate cases, failed-interface scenarios, review changes, report revisions, and release/reconciliation steps. Edge cases often reveal more about workflow readiness than a smooth-path demonstration.

Measuring Genomics Workflow Outcomes Without Overclaiming

Workflow outcomes should be reported through evidence, not impressions. Before including a metric, define its baseline, scope, time period, source system, and owner. If those elements are not available for publication, use careful qualitative language and attribute the observation to the project team.

The most useful measures are operational:

These measures show whether structured intake, controlled interfaces, traceable review, and managed reporting are changing the day-to-day operating model.

Genomics Workflow Assessment: The Next Step

A modern laboratory workflow must connect data quality, integration discipline, analytical review, and reporting controls across the full case lifecycle. The goal is not to remove professional judgment or to suggest that every laboratory should use the same architecture. The goal is to make the workflow understandable, traceable, and manageable when real-world exceptions arise.

Start with one question: Can an operator determine, without manual reconstruction, what happened to a case, who approved it, which version was used, and what must happen next? If the answer is no, the laboratory has a practical basis for identifying the controls, interfaces, and operating decisions that need attention.

NonStop provides workflow software and bioinformatics services for genomics and advanced diagnostics laboratories, including structured requisition intake, integration support, variant analysis, and clinical reporting capabilities.